Zobrazeno 1 - 10
of 215
pro vyhledávání: '"Andrew G, Bushmakin"'
Autor:
Victoria Navarro-Compán, Atul Deodhar, Rachid Bahiri, Andrew G. Bushmakin, Joseph C. Cappelleri, Jihane Rammaoui
Publikováno v:
Arthritis Research & Therapy, Vol 26, Iss 1, Pp 1-11 (2024)
Abstract Background Tofacitinib is an oral Janus kinase inhibitor for treatment of ankylosing spondylitis (AS). Time to improvement in core domains of AS was estimated in tofacitinib-treated patients with AS. Methods This post hoc analysis used phase
Externí odkaz:
https://doaj.org/article/8c1617d1f06045b4bfa00d63dc2afbfb
Autor:
Thomas J. Schnitzer, Philip G. Conaghan, Francis Berenbaum, Lucy Abraham, Joseph C. Cappelleri, Andrew G. Bushmakin, Lars Viktrup, Ruoyong Yang, Mark T. Brown
Publikováno v:
Advances in Rheumatology, Vol 64, Iss 1, Pp 1-5 (2024)
Abstract Background To illustrate how (standardised) effect sizes (ES) vary based on calculation method and to provide considerations for improved reporting. Methods Data from three trials of tanezumab in subjects with osteoarthritis were analyzed. E
Externí odkaz:
https://doaj.org/article/f628c39303c84570a9c6556e1bdaf14a
Autor:
Lars Erik Kristensen, Victoria Navarro-Compán, Marina Magrey, Andrew G. Bushmakin, Joseph C. Cappelleri, Arne Yndestad, Oluwaseyi Dina, Peter C. Taylor
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 4, Pp 1073-1087 (2023)
Abstract Introduction Tofacitinib is an oral Janus kinase inhibitor for treatment of ankylosing spondylitis (AS). Using mediation modelling, we describe interrelationships between fatigue, pain, morning stiffness, C-reactive protein (CRP) and tofacit
Externí odkaz:
https://doaj.org/article/3c522789b45749f6a6d68b464bcbeb6a
Autor:
David Cella, William R. Lenderking, Peter Chongpinitchai, Andrew G. Bushmakin, Oluwaseyi Dina, Lisy Wang, Joseph C. Cappelleri, Victoria Navarro-Compán
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 6, Iss 1, Pp 1-10 (2022)
Plain English summary Ankylosing spondylitis (AS) is a disease that causes pain and stiffness in the spine. AS is a chronic disease. Most people with AS experience fatigue (a feeling of being very tired or exhausted). People with more severe AS tend
Externí odkaz:
https://doaj.org/article/6e9e80fde3c949509ec55f332601f2dc
Autor:
Thomas J. Schnitzer, Rebecca L. Robinson, Leslie Tive, Joseph C. Cappelleri, Andrew G. Bushmakin, James Jackson, Mia Berry, Sophie Barlow, Chloe Walker, Lars Viktrup
Publikováno v:
BMC Musculoskeletal Disorders, Vol 23, Iss 1, Pp 1-11 (2022)
Abstract Background Osteoarthritis (OA) is typically associated with pain, but many patients are not treated. Methods This point in time study explored factors associated with treatment status, using logistic regression of data from the Adelphi OA Di
Externí odkaz:
https://doaj.org/article/1351e9edafac4d478b2f29c1d7397972
Autor:
Dafna D. Gladman, Laura C. Coates, Joseph Wu, Lara Fallon, Elizabeth D. Bacci, Joseph C. Cappelleri, Andrew G. Bushmakin, Philip S. Helliwell
Publikováno v:
Arthritis Research & Therapy, Vol 24, Iss 1, Pp 1-12 (2022)
Abstract Background This study examined the time to clinically meaningful response in patients with active psoriatic arthritis treated with tofacitinib, adalimumab, or placebo switching to tofacitinib. Methods Data were from two phase 3 studies, OPAL
Externí odkaz:
https://doaj.org/article/c9bfa5f71ac240f1b10032db6b72a818
Autor:
Laura C. Coates, Andrew G. Bushmakin, Oliver FitzGerald, Dafna D. Gladman, Lara Fallon, Joseph C. Cappelleri, Ming-Ann Hsu, Philip S. Helliwell
Publikováno v:
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-12 (2021)
Abstract Background In psoriatic arthritis (PsA), further understanding of the relationships between clinical measures and patient-reported outcomes (PROs) is needed. This post hoc analysis evaluated associations between minimal disease activity (MDA
Externí odkaz:
https://doaj.org/article/cd476b3170c24c1ab4878ba4f7f11a0e
Autor:
Aaron Yarlas, Stephen Maher, Martha Bayliss, Andrew Lovley, Joseph C. Cappelleri, Andrew G. Bushmakin, Marco D. DiBonaventura
Publikováno v:
Journal of Patient-Centered Research and Reviews, Vol 7, Iss 2, Pp 189-205 (2020)
Purpose: The 32-item Inflammatory Bowel Disease Questionnaire (IBDQ-32) is the most frequently used instrument to capture disease-specific quality of life in randomized clinical trials for ulcerative colitis. This review and meta-analysis provides th
Externí odkaz:
https://doaj.org/article/327625e280bc446bbf768cf9a05d8f0a
Autor:
Roy Fleischmann, Peter C Taylor, Kurt de Vlam, Joseph C Cappelleri, Alexis Ogdie, Lara Fallon, John Woolcott, Valderilio Azevedo, Andrew G Bushmakin
Publikováno v:
RMD Open, Vol 7, Iss 2 (2021)
Background Pain is a core domain of psoriatic arthritis (PsA). This post hoc analysis evaluated time to pain improvement and the impact of baseline pain severity on pain response in patients with PsA receiving tofacitinib.Methods Data from two trials
Externí odkaz:
https://doaj.org/article/5fe24c3d2787420292994dddcc83afca
Autor:
Eric L. Simpson, Gil Yosipovitch, Andrew G. Bushmakin, Joseph C. Cappelleri, Thomas Luger, Sonja Ständer, Wynnis L. Tom, William C. Ports, Michael A. Zielinski, Anna M. Tallman, Huaming Tan, Robert A. Gerber
Publikováno v:
Acta Dermato-Venereologica, Vol 99, Iss 9, Pp 756-761 (2019)
Crisaborole ointment is a nonsteroidal phosphodiesterase 4 inhibitor for the treatment of mild to moderate atopic dermatitis. Using pooled data from two phase 3 studies (NCT02118766/NCT02118792), mediation modeling determined the interrelationship am
Externí odkaz:
https://doaj.org/article/e2d64085c0c24480a5e91c42823e54ba